Caris Life Sciences, Inc. (CAI): Depreciation & Amortization
$22.61M
Year ended 2025-12-31
$20.76M
Trailing 12 months to 2026-06-30
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $22.61M | -53.8% | 2026-03-03, From 2025-01-01 |
| 2024-12-31 | $48.91M | -0.2% | 2026-03-03, From 2024-01-01 |
| 2023-12-31 | $49.00M | n/a | 2026-03-03, From 2023-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $22.61M | -53.8% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $39.74M | -6.3% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $21.41M | -8.7% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $15.02M | +5.8% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $40.77M | +154.9% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $136.10M | +8.6% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $24.12M | -3.2% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $6.90M | -1.4% |
| Natera, Inc. (NTRA) | 2025-12-31 | $41.76M | +34.9% |
Compare CAI, GH, VCYT, CDNA side by side · Screen every company in Services-Medical Laboratories ↗